A detailed history of Pinnacle Associates LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pinnacle Associates LTD holds 474,065 shares of MRK stock, worth $47 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
474,065
Previous 460,764 2.89%
Holding current value
$47 Million
Previous $57 Million 5.62%
% of portfolio
0.85%
Previous 0.92%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$111.15 - $128.97 $1.48 Million - $1.72 Million
13,301 Added 2.89%
474,065 $53.8 Million
Q2 2024

Jul 30, 2024

SELL
$123.8 - $132.96 $1.16 Million - $1.24 Million
-9,338 Reduced 1.99%
460,764 $57 Million
Q1 2024

Apr 26, 2024

SELL
$113.24 - $131.95 $448,770 - $522,917
-3,963 Reduced 0.84%
470,102 $62 Million
Q4 2023

Jan 19, 2024

SELL
$100.18 - $109.02 $109,296 - $118,940
-1,091 Reduced 0.23%
474,065 $51.7 Million
Q3 2023

Oct 23, 2023

SELL
$102.95 - $114.33 $401,505 - $445,887
-3,900 Reduced 0.81%
475,156 $48.9 Million
Q2 2023

Jul 26, 2023

BUY
$108.61 - $118.38 $4.79 Million - $5.22 Million
44,092 Added 10.14%
479,056 $55.3 Million
Q1 2023

May 04, 2023

SELL
$102.94 - $114.86 $2.38 Million - $2.66 Million
-23,132 Reduced 5.05%
434,964 $46.3 Million
Q4 2022

Jan 31, 2023

BUY
$87.44 - $112.11 $49,403 - $63,342
565 Added 0.12%
458,096 $50.8 Million
Q4 2022

Jan 25, 2023

SELL
$87.44 - $112.11 $1.23 Million - $1.58 Million
-14,123 Reduced 2.99%
457,531 $0
Q3 2022

Oct 31, 2022

SELL
$84.53 - $94.96 $367,029 - $412,316
-4,342 Reduced 0.91%
471,654 $40.6 Million
Q2 2022

Aug 02, 2022

SELL
$83.49 - $94.64 $1.96 Million - $2.22 Million
-23,456 Reduced 4.7%
475,996 $43.4 Million
Q1 2022

May 05, 2022

BUY
$73.51 - $82.4 $605,060 - $678,234
8,231 Added 1.68%
499,452 $41 Million
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $2.63 Million - $3.29 Million
36,355 Added 7.99%
491,221 $37.6 Million
Q3 2021

Oct 19, 2021

BUY
$71.68 - $78.83 $1.25 Million - $1.37 Million
17,430 Added 3.98%
454,866 $34.2 Million
Q2 2021

Aug 02, 2021

BUY
$70.31 - $77.77 $808,283 - $894,043
11,496 Added 2.7%
437,436 $34 Million
Q1 2021

May 12, 2021

BUY
$68.86 - $81.11 $2.3 Million - $2.7 Million
33,330 Added 8.49%
425,940 $32.8 Million
Q4 2020

Jan 26, 2021

SELL
$71.77 - $79.65 $376,433 - $417,764
-5,245 Reduced 1.32%
392,610 $32.1 Million
Q3 2020

Oct 23, 2020

SELL
$73.18 - $82.95 $482,475 - $546,889
-6,593 Reduced 1.63%
397,855 $33 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $744,902 - $847,615
-10,578 Reduced 2.55%
404,448 $31.3 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $1.49 Million - $2.06 Million
23,498 Added 6.0%
415,026 $31.9 Million
Q4 2019

Feb 03, 2020

SELL
$77.58 - $87.54 $3.08 Million - $3.48 Million
-39,728 Reduced 9.21%
391,528 $35.6 Million
Q3 2019

Nov 08, 2019

SELL
$76.08 - $82.93 $8.56 Million - $9.33 Million
-112,540 Reduced 20.7%
431,256 $36.3 Million
Q2 2019

Aug 05, 2019

SELL
$69.84 - $81.59 $285,366 - $333,376
-4,086 Reduced 0.75%
543,796 $45.6 Million
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $2.15 Million - $2.45 Million
-30,850 Reduced 5.33%
547,882 $45.6 Million
Q4 2018

Feb 05, 2019

SELL
$65.24 - $75.71 $2.31 Million - $2.68 Million
-35,410 Reduced 5.77%
578,732 $44.2 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $6.12 Million - $7.2 Million
106,121 Added 20.89%
614,142 $43.6 Million
Q2 2018

Aug 08, 2018

SELL
$50.83 - $59.72 $1.39 Million - $1.63 Million
-27,282 Reduced 5.1%
508,021 $30.8 Million
Q1 2018

May 11, 2018

SELL
$50.96 - $59.23 $127,400 - $148,075
-2,500 Reduced 0.46%
535,303 $29.2 Million
Q4 2017

Feb 12, 2018

BUY
$51.62 - $61.64 $1.81 Million - $2.16 Million
34,987 Added 6.96%
537,803 $30.3 Million
Q3 2017

Nov 13, 2017

SELL
$58.67 - $63.13 $658,336 - $708,381
-11,221 Reduced 2.18%
502,816 $32.2 Million
Q2 2017

Aug 09, 2017

BUY
N/A
514,037
514,037 $32.9 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pinnacle Associates LTD Portfolio

Follow Pinnacle Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Associates LTD with notifications on news.